{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:44:42Z","timestamp":1789425882640,"version":"build-2803163510"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/ajp.0b013e3181eef686","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T11:16:07Z","timestamp":1284462967000},"page":"656-666","source":"Crossref","is-referenced-by-count":70,"title":["A Prospective Study of the Herpes Zoster Severity of Illness"],"prefix":"10.1097","volume":"26","author":[{"given":"M\u00e9lanie","family":"Drolet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron J.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Schmader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Oxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Camden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Mansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210204","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice. Herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-2-20210204","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<131::AID-RMV198>3.0.CO;2-7","article-title":"The pathology of herpes zoster and its bearing on sensory localisation","volume":"7","author":"Head","year":"1997","journal-title":"Rev Med Virol"},{"key":"R3-2-20210204","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"R4-2-20210204","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM198312083092306","article-title":"Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus","volume":"309","author":"Weller","year":"1983","journal-title":"N Engl J Med"},{"key":"R5-2-20210204","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"R6-2-20210204","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"Edmunds","year":"2001","journal-title":"Vaccine"},{"key":"R7-2-20210204","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"key":"R8-2-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archderm.1957.01550140037006","article-title":"The outcome of patients with herpes zoster","volume":"75","author":"De Moragas","year":"1957","journal-title":"AMA Arch Derm"},{"key":"R9-2-20210204","first-page":"571","article-title":"Postherpetic neuralgia","volume":"25","author":"Hope-Simpson","year":"1975","journal-title":"J R Coll Gen Pract"},{"key":"R10-2-20210204","first-page":"246","article-title":"Varicella Zoster Virus: Virology and Clinical Management","author":"Oxman","year":"2000"},{"key":"R11-2-20210204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(96)03122-3","article-title":"Pain and its persistence in herpes zoster","volume":"67","author":"Dworkin","year":"1996","journal-title":"Pain"},{"key":"R12-2-20210204","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the Brief Pain Inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"key":"R14-2-20210204","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"R15-2-20210204","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination","volume":"24","author":"de Melker","year":"2006","journal-title":"Vaccine"},{"key":"R16-2-20210204","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","article-title":"Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"25","author":"Pellissier","year":"2007","journal-title":"Vaccine"},{"key":"R17-2-20210204","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","article-title":"Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older","volume":"27","author":"Stein","year":"2009","journal-title":"Vaccine"},{"key":"R18-2-20210204","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S0950268808000678","article-title":"Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom","volume":"137","author":"Gauthier","year":"2009","journal-title":"Epidemiol Infect"},{"key":"R20-2-20210204","article-title":"Measuring Self-reported Population Health: an International Perspective Based on EQ-5D","author":"Szende","year":"2004"},{"key":"R21-2-20210204","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2165\/0002512-200825120-00002","article-title":"Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient","volume":"25","author":"Johnson","year":"2008","journal-title":"Drugs Aging"},{"issue":"1","key":"R22-2-20210204","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R23-2-20210204","doi-asserted-by":"crossref","DOI":"10.1201\/9781420035438","article-title":"Design and Analysis of Quality of Life Studies in Clinical Trials","author":"Fairclough","year":"2002"},{"issue":"suppl 1","key":"R24-2-20210204","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.jpain.2007.10.008","article-title":"Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia","volume":"9","author":"Dworkin","year":"2008","journal-title":"J Pain"},{"key":"R25-2-20210204","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/sim.851","article-title":"Phase specific analysis of herpes zoster associated pain data: a new statistical approach","volume":"20","author":"Arani","year":"2001","journal-title":"Stat Med"},{"key":"R26-2-20210204","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0885-3924(02)00393-7","article-title":"Clinical applications for change-point analysis of herpes zoster pain","volume":"23","author":"Desmond","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"R27-2-20210204","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.pain.2007.02.004","article-title":"Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: Prospective Prognostic Study","volume":"132","author":"Opstelten","year":"2007","journal-title":"Pain"},{"issue":"suppl 1","key":"R28-2-20210204","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpain.2007.10.002","article-title":"Natural history and treatment of herpes zoster","volume":"9","author":"Schmader","year":"2008","journal-title":"J Pain"},{"key":"R29-2-20210204","article-title":"Statistical Methods. 6th ed","author":"Snedecor","year":"1967"},{"key":"R30-2-20210204","article-title":"Multiple Regression in Behavioral Research. Explanation and Prediction","author":"Pedhazur","year":"1982"},{"key":"R31-2-20210204","doi-asserted-by":"crossref","DOI":"10.1002\/0471725153","article-title":"Regression Diagnostics: Identifying Influential Data and Sources of Collinearity","author":"Belsley","year":"1980"},{"key":"R32-2-20210204","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R33-2-20210204","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archfami.9.9.863","article-title":"Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older","volume":"9","author":"Tyring","year":"2000","journal-title":"Arch Fam Med"},{"key":"R34-2-20210204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/314562","article-title":"Herpes zoster: risk categories for persistent pain","volume":"179","author":"Whitley","year":"1999","journal-title":"J Infect Dis"},{"key":"R35-2-20210204","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/fampra\/19.5.471","article-title":"Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database","volume":"19","author":"Opstelten","year":"2002","journal-title":"Fam Pract"},{"key":"R36-2-20210204","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","article-title":"Risk factors for postherpetic neuralgia in patients with herpes zoster","volume":"62","author":"Jung","year":"2004","journal-title":"Neurology"},{"key":"R37-2-20210204","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ejpain.2005.11.002","article-title":"Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?","volume":"10","author":"Coen","year":"2006","journal-title":"Eur J Pain"},{"key":"R38-2-20210204","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jmv.21254","article-title":"Clinical and psychosocial correlates of post-herpetic neuralgia","volume":"80","author":"Volpi","year":"2008","journal-title":"J Med Virol"},{"key":"R39-2-20210204","article-title":"Herpes Zoster and Postherpetic Neuralgia in General Practice","author":"Opstelten","year":"2005"},{"key":"R40-2-20210204","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","article-title":"Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up","volume":"321","author":"Helgason","year":"2000","journal-title":"Bmj"},{"issue":"1","key":"R41-2-20210204","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1086\/514260","article-title":"Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients","volume":"178","author":"Dworkin","year":"1998","journal-title":"J Infect Dis"},{"key":"R42-2-20210204","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","article-title":"Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group","volume":"125","author":"Whitley","year":"1996","journal-title":"Ann Intern Med"},{"key":"R43-2-20210204","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","article-title":"Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group","volume":"123","author":"Tyring","year":"1995","journal-title":"Ann Intern Med"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AJP.0b013e3181eef686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:32:40Z","timestamp":1620945160000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-201010000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e3181eef686","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}